Congratulations to Dr. Gang Zheng, Senior Scientist and Associate Research Director at the Princess Margaret Cancer Centre, for being named winner of the 2022 Credible Professional Accountable Canadian Professional Achievement Award (CPAC). The award recognizes the achievements of immigrant professionals who have achieved outstanding success and prominent status in their profession.

Dr. Zheng is a world leader in the invention of nanotechnology for the diagnosis and treatment of cancer. His groundbreaking discovery – porphysome nanotechnology – was the first cancer nanomedicine that could light up tumours, kill tumours with light, and detect tumours through PET and MRI scans.

Dr. Zheng's work was recognized as one of the Top Ten Cancer Breakthroughs of 2011 by the Canadian Cancer Society. His research has been featured in more than 200 high-ranking, peer-reviewed publications, such as Nature Minerals and Nature Nanotechnology, and was previously awarded with the UHN Inventor of the Year Award.

Congratulations to Dr. Robert Grant, medical oncologist and researcher at the Princess Margaret Cancer Centre, for being one of the four inaugural recipients of the Marathon of Hope Cancer Centre's Network Clinician-Scientist Award.

The funding from the award will be used to develop new methods to personalize treatments for patients with pancreatic cancer. To achieve his goal, Dr. Grant will use samples from pancreatic cancer patients to create thousands of organoids, and use a screening platform to see how these organoids respond to approximately 3,000 different drugs.

This drug-screening process will enable Dr. Grant and his team to create a comprehensive dataset of each tumour's response to each drug. This dataset will work with artificial intelligence to create a robust program that can predict how patient's pancreatic cancer will respond to a drug based on their specific biology. Read more.

Congratulations to Dr. York Pei, (R in photo), for receiving the Medal for Research Excellence from the Kidney Foundation of Canada. The award is given annually to a Canadian researcher who is recognized for career accomplishments in kidney research.

Dr. Pei is the Director of the Centre for Innovative Management of Polycystic Kidney Disease (PKD) at UHN, a Senior Scientist at the Toronto General Research Institute and a professor with the Department of Medicine, Division of Nephrology at the University of Toronto (U of T).

Dr. Pei's research career has mainly centered on identifying the genetic factors involved in the initiation or progression of genetic kidney diseases as a target for developing novel diagnostic tests and therapies.

"Dr. Pei has been a major figure in PKD research over the past two decades," Dr. Christopher Chan, Director of Nephrology, UHN. "His work has redefined the diagnostic and therapeutic approaches to ADPKD and has helped countless patients with this disease."

Dr. Pei has published more than 150 peer-reviewed articles, has collaborated widely with researchers nationally and internationally and has trained numerous clinical and research fellows in hereditary kidney disease. Dr. Pei also founded the Centre for Innovative Management for Polycystic Kidney Disease in 2015 with the goal of developing a world-class PKD translational research program in Canada.

"I am truly honoured and most grateful to receive this prestigious recognition from the Kidney Foundation of Canada (KFOC)," Dr. Pei says. "The funding from the KFOC over the past two decades has played a critical role in making my research in polycystic kidney disease possible and, at times served as a lifeline in a challenging funding environment."

Congratulations to Dr. Frances Chung, consultant in the Department of Anesthesia and Pain Management at Toronto Western Hospital and ResMed Research Chair of Anesthesia, Sleep, and Perioperative Medicine, for receiving a Research.com Best Female Scientist Award 2022 award.

Dr. Chung's award recognizes her impact in Surgery, Internal medicine and Anesthesia. She is ranked among the best 1000 female scientists in the world (No. 820) and among the ranked best female scientists in Canada (No. 25). Her H index is 102, citations 37,507 and publications 378.

Research.com ranking of top female scientists in Canada is based on data collected from Microsoft Academic Graph on 06-12-2021. Position in the ranking is based on a scientist's general H-index.

Our ranking of top female scientists in Canada includes leading female scientists from all major areas of science. It was based on a meticulous examination of 166,880 scientists on Google Scholar and Microsoft Academic Graph.

Dr. Chung's research interests are in sleep apnea, patient safety, and perioperative medicine. Her work led to the development of the STOP-Bang questionnaire, a screening tool for patients with undiagnosed obstructive sleep apnea that has been adopted worldwide.

Congratulations to Dr. Dafna Gladman, Senior Rheumatologist and Senior Scientist at UHN's Schroeder Arthritis Institute and UHN's Krembil Research Institute, for being the third female scientist, 12th scientist in Canada, 465th in the world for the Research.com in the Best Medicine Scientists 2022 category.

This award highlights the level of research performed by the scientists, by assembling a reliable list of leading scientists from the area of Medicine, based on a meticulous examination of 166,880 scientists on Microsoft Academic Graph.

Dr. Gladman is a clinician-scientist doing both clinical and translation research focused on lupus and psoriatic arthritis. She is primarily based in Toronto Western Hospital.

Congratulations to Dr. Karen D. Davis, Senior Scientist, Division Head and Division of Brain, Imaging, and Behaviour at UHN's Krembil Brain Institute at Toronto Western Hospital, for being ranked No. 27 among top female scientist in Canada and No. 899 in the world on Research.com. Dr. Davis was also ranked No. 18 in Canada for neuroscience and No. 325 in the Best Neuroscience Scientists in Canada 2022 category.

This award highlights the level of research performed by the scientists, by compiling a reliable list of leading scientists from the area of neuroscience, based on a meticulous examination of 166,880 scientists on Microsoft Academic Graph.

Dr. Karen Davis is a Senior Scientist at UHN's Krembil Brain Institute, Toronto Western Hospital and professor at the U of T. She is a pioneer in using electrophysiological and brain imaging approaches to investigate acute pain, and is active in neuroethics. She previously served as past-president of the Canadian Pain Society and is the incoming Editor-in-Chief of PAIN (the official journal of the International Association for the Study of Pain).

Congratulations to Dr. Claire Bombardier, Senior Scientist, Division of Support, Systems, & Outcomes and Principal Investigator, Ontario Best Practices Research Initiative for the Toronto General Hospital Research Institute, for being among one of 2022 Ranking of Top 10000 Female Scientists in the World in the Best Female Scientists in Canada 2022 Ranking category. Dr. Bombardier was ranked No. 15 in Canada and No. 487 in the world by Research.com.

This award shows the amazing breadth and depth and impact of female researchers locally and internationally. It also shows how prolific Dr. Bombardier is with 394 publications as of December, and how influential and relevant her publications are with so many citations – a total of 90,121.

Dr. Bombardier is Senior Scientist for the Toronto General Research Institute and is the co-Lead for ECHO-Rheumatology. Former titles include: Director of Rheumatology for the University of Toronto and co-Scientific Director at the Canadian Arthritis Network.

Dr. Bombardier has held a Pfizer Research Chair in Rheumatology and a Canada Research Chair in Knowledge Transfer for Musculoskeletal Care. In 2005, Dr. Bombardier founded the Ontario Best Practice Research Initiative (OBRI – www.obri.ca) to monitor the safety and efficacy of treatments for people with rheumatoid arthritis to improve treatment and quality of care for people in Ontario.

Back to Top